Literature DB >> 27418080

Conservative surgical management of patients with bisphosphonate-related osteonecrosis of the jaws: a series of 120 patients.

M Nisi1, F La Ferla1, D Karapetsa1, S Gennai2, L Ramaglia3, F Graziani1, M Gabriele1.   

Abstract

We evaluated retrospectively the efficacy of local resection for patients who presented with bisphosphonate-related osteonecrosis of the jaw (BRONJ). We studied 120 subjects with who required local resection of 129 BRONJ lesions that had not responded to medical treatment. The primary outcomes were improvement of the clinical stage of BRONJ and resolution of disease, and the secondary outcome was the influence of the surgeon's experience on the healing of the lesions. Age, sex, underlying diseases, smoking, and coexisting conditions were recorded. Logistic regression analysis was used to isolate factors that could potentially affect the outcome. Most of the lesions (n=107, 84%) improved postoperatively, 20 showed no change, and one got worse. One patient died. Stratification indicated complete healing and total resolution of disease for all 26 stage I lesions, improvement for 67 of the 77 stage II lesions, and for 14 of the 25 stage III lesions. The disease resolved in 67 of the 69 stage II lesions, and 14 of the stage III cases. Logistic regression indicated that smoking and the stage of disease could affect the outcome. Analysis of the surgeons' learning curve showed that performance improved significantly over time. Complete healing after local resection increased from 40% to 80% over a period of eight years (p<0.001). We conclude that local resection may be the treatment of choice in BRONJ stages I and II. Stage III might be better treated with either resection or clinical monitoring according to the condition of the patient.
Copyright © 2016 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BRONJ; Conservative resection; Retrospective study

Mesh:

Substances:

Year:  2016        PMID: 27418080     DOI: 10.1016/j.bjoms.2016.06.015

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  10 in total

Review 1.  A literature review of perioperative antibiotic administration in surgery for medication-related osteonecrosis of the jaw.

Authors:  Masaya Akashi; Junya Kusumoto; Daisuke Takeda; Takashi Shigeta; Takumi Hasegawa; Takahide Komori
Journal:  Oral Maxillofac Surg       Date:  2018-10-16

2.  Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.

Authors:  Masaya Akashi; Satoshi Wanifuchi; Eiji Iwata; Daisuke Takeda; Junya Kusumoto; Shungo Furudoi; Takahide Komori
Journal:  Oral Maxillofac Surg       Date:  2017-12-09

3.  Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.

Authors:  Mitsunobu Otsuru; Saki Hayashida; Kota Morishita; Maho Murata; Sakiko Soutome; Miho Sasaki; Yukinori Takagi; Misa Sumi; Masahiro Umeda
Journal:  Int J Environ Res Public Health       Date:  2022-06-17       Impact factor: 4.614

4.  Relationship between drug holiday of the antiresorptive agents and surgical outcome of medication-related osteonecrosis of the jaw in osteoporosis patients.

Authors:  Kota Morishita; Sakiko Soutome; Mitsunobu Otsuru; Saki Hayashida; Maho Murata; Miho Sasaki; Yukinori Takagi; Misa Sumi; Masahiro Umeda
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

5.  Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol.

Authors:  Luca Ramaglia; Agostino Guida; Vincenzo Iorio-Siciliano; Alessandro Cuozzo; Andrea Blasi; Anton Sculean
Journal:  Clin Oral Investig       Date:  2018-01-13       Impact factor: 3.573

6.  Nonsurgical Management of Medication-Related Osteonecrosis of the Jaws Using Local Wound Care.

Authors:  Danny Hadaya; Akrivoula Soundia; Earl Freymiller; Tristan Grogan; David Elashoff; Sotirios Tetradis; Tara L Aghaloo
Journal:  J Oral Maxillofac Surg       Date:  2018-05-29       Impact factor: 1.895

7.  Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study.

Authors:  Rodolfo Mauceri; Vera Panzarella; Laura Maniscalco; Alberto Bedogni; Maria Ester Licata; Antonino Albanese; Francesca Toia; Enzo Maria Giuseppe Cumbo; Giuseppina Mazzola; Olga Di Fede; Giuseppina Campisi
Journal:  Biomed Res Int       Date:  2018-08-19       Impact factor: 3.411

Review 8.  Dental Implant Placement in Patients on Bisphosphonate Therapy: a Systematic Review.

Authors:  Rokas Gelazius; Lukas Poskevicius; Dalius Sakavicius; Vaidas Grimuta; Gintaras Juodzbalys
Journal:  J Oral Maxillofac Res       Date:  2018-09-30

9.  Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?

Authors:  Sakiko Soutome; Saki Hayashida; Madoka Funahara; Yuki Sakamoto; Yuka Kojima; Souichi Yanamoto; Masahiro Umeda
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

10.  Combined approach to treatment of advanced stages of medication-related osteonecrosis of the jaw patients.

Authors:  Onur Şahin; Ender Akan; Birkan Tatar; Ceren Ekmekcioğlu; Nuri Ünal; Onur Odabaşı
Journal:  Braz J Otorhinolaryngol       Date:  2021-05-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.